Use of proton pump inhibitors (PPIs) is quite common among renal transplant recipients and reduced kidney functions and hypomagnesemia with the use of PPIs have been reported. In this study, investigation of the effects of PPI use on the outcome of kidney transplant recipients is aimed.
Use of proton pump inhibitors (PPIs) is frequent among renal transplant recipients due to the common use of glucocorticoids in immunosuppresive regimens after transplantation. Reduced kidney functions and hypomagnesemia with the use of PPIs have been reported in various patient populations. However, few studies examined the effects of PPIs on kidney transplant recipients. Therefore, the aim of this study is to investigate the effects of PPI and/or histamine H2 receptor antagonist use on serum magnesium levels, allograft functions and survival in kidney transplant recipients.
Study Type
OBSERVATIONAL
Enrollment
300
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
Istanbul, Turkey (Türkiye)
Graft survival
Time frame: 5-10 years
Graft rejection
Time frame: 5-10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.